Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 1, 2018

Study Completion Date

September 1, 2018

Conditions
Colorectal CancerColorectal CarcinomaStage IV Colon Cancer
Interventions
DIAGNOSTIC_TEST

Measurement of platelet count at diagnosis

Blood samples were drawn by expert phlebotomists in vacuum blood tubes containing K2-EDTA (Terumo Europe NV, Leuven, Belgium). The complete blood cell count (CBC) was performed using Advia 2120 (Siemens Healthcare Diagnostics, Tarrytown NY, USA). The local reference range for platelets was 150-400 x 109/L. The same analyser was used throughout the study period, and the quality and reproducibility of test results was validated by data of both internal quality control and external quality assessment

Trial Locations (1)

37134

Chirurgia Generale ed Epatobiliare, Policlinico GB Rossi, Verona

All Listed Sponsors
lead

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

NCT03717519 - Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases | Biotech Hunter | Biotech Hunter